Abbott Laboratories Stock Forecast
NYSE: ABTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:02 PM ET · Delayed 15 min
Pre-market: 98.76 +0.27%
ABT analyst consensus
Consensus (28 analysts)
strong_buy
Avg. price target
$120.72+22.57%
- Strong buy 5
- Buy 19
- Hold 4
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 28 Wall Street analysts covering Abbott Laboratories (2026-10-07), 24 rate the stock a buy or strong buy, 4 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $120.72, with a high estimate of $135.00 and a low estimate of $103.00. The average target implies upside of 22.6% from the current price of $98.49.
The spread between the highest and lowest targets is 31.1%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for ABT.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 5 | 18% |
| Buy | 19 | 68% |
| Hold | 4 | 14% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $103.00 | +4.58% |
| Average target | $120.72 | +22.57% |
| High target | $135.00 | +37.07% |